Infectious complications from heart transplantation. Prospective study for the first six years of a transplantation program;Complicaciones infecciosas de trasplante cardíaco. Estudio prospectivo durante los seis primeros años de programa de trasplante

Revista Clinica Espanola

Volumn 199, Issue 8, 1999, Pages 489-495

  Bernabeu Wittel, M ^a   Canas Garci a Otero E ^a   Herrero Romero, M ^a   Ordonez Fernandez A ^a   Martinez Martinez A ^a   Perez Bernal J ^a   Cisneros Herreros, J M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Heart transplantation; Infection; Risk factors

Indexed keywords

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BACTERIAL INFECTION; COMPARATIVE STUDY; CROSS INFECTION; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; INCIDENCE; LENGTH OF STAY; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; MYCOSIS; PNEUMONIA; PROSPECTIVE STUDY; RISK FACTOR; TIME; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; BACTERIAL INFECTIONS; CROSS INFECTION; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOSES; PNEUMONIA; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; VIRUS DISEASES;

EID: 0033176031     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Matesanz R. Donaciôn y trasplante en España. Medicina Intensiva 1993; 17:311-316
2. Matesanz R. Generosidad de los españoles y trasplante ce órganos. Med Clin (Barc) 1995; 105:416-417.
3. Arizón del Prado JM. Registro Nacional de Trasplante Cardíaco. Séptimo Informe (1984/1995). Rev Esp Cardiol 1996; 49:781-787.
4. Arizón del Prado JM. Registro Nacional de Trasplante Cardíaco. Octavo Informe (1984/1996). Rev Esp Cardiol 1997; 50:826-832
5. Hofflin JM, Potasman I, Baldwin JC, Oyer PE, Stinson EB, Remington JS. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med 1987; 106:209-216.
6. Reid KR, Menkis AH, Novick RJ, et al. Reduced incidence of severe infection after heart transplantation with low intensity immunosupression. J Heart Lung Transplant 1991; 10:894-900.
7. Miller LW, Naftel DC, Bourge RC, et al. Infection after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 1994; 13:381-392.
8. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standarization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Transplant 1990; 9:587-593.
9. Gorensek MJ, Stewart RW, Keys TF, Mehta AC, McHenry MC, Goormastic M. A multivariate analysis of risk factors for pneumonia following cardiac transplantation. Transplantation 1988; 46:860-865.
10. Waser M, Maggiorini M, Lüthy A, et al. Infectious complications in 100 consecutive heart transplant recipients. Eur J Clin Microbiol Infect Dis 1994; 13:12-18.
11. Smart FW, Naftel DC, Costanzo MR, et al. Risk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 1996; 15:329-341.
12. Behrendt DM, Billingham ME, Boucek MM, Marxmiller JM, Rose EA, Marcelletti C. Session VI: Rejection/infection: the limits of heart transplantation success. J Heart Lung Transplant 1991; 10:841-847.
13. Arizón JM, Catalán M, Concha M, Fernández M, Llorens R. Trasplante cardíaco en España. Análisis de supervivencia precoz y tardía. En: Concha M, Arizón JM, Crespo M, Llorens R, eds. Trasplante cardíaco. Conferencia de consenso nacional 1996. Barcelona: J. Uriach & Cía, SA, 1996: 11-37.
14. Muñoz P, Rivero M, Palomo J, Muñoz R, Rodriguez-Creixems M, Bouza E. Prospective follow-up of infectious complications in 100 heart transplant recipients. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 20-October 1, Toronto, Canada, 1997 (abstract n.o J-98).
15. Gavilán F, Martínez L, Torre-Cisneros J. Infección bacteriana en el trasplante de órgano sólico. Enferm Infecc Microbiol Clin 1997; 15 (suppl 2):12-21.
16. Dummer JS. Infectious complications of transplantation. Cardiovasc Clin 1990; 20:163-173.
17. Kusne S, Schwartz M, Breinig MK, et al. Herpes simplex virus hepatitis after solid organ transplantation in adults. J Infect Dis 1991; 163:1.001-1.007.
18. Kirklin JK, Naftel DC, Levine TB, et al. Cytomegalovirus after heart transplantation. Risk factors for infection and death: a multiinstitutional study. J Heart Lung Transplant 1994; 13:394-404.
19. Grossi P, Minoli L, Percivalle E, Irish W, Vigano M, Gerna G. Clinical and virological monitoring of human cytomegalovirus infectior in 294 heart transplant recipients. Transplantation 1995; 59:847-851.
20. Merigan TC, Renlund DG, Keay S, et al. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med 1992; 326:1.182-1.186.
21. Steel HM, Murday AJ. Cytomegalovirus as a cause of morbidity in heart transplantation. Transplantation 1996; 62:492-496.
22. Dunn DL, Mayoral J, Guillinham KJ, et al. Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. Transplantation 1991; 51:98-106.
23. Schulman LL, Reison DS, Austin JH, Rose EA. Cytomegalovirus pneumonitis after cardiac transplantation. Arch Intern Med 1991; 151:1.118-1.124.
24. Cisneros JM, Muñoz P, Torre-Cisneros J, Gurgui M. Rodríguez-Hernández MJ, Aguado JM. Pneumonia after heart transplantation. A multiinstitutional study. Clin Infect Dis 1998; 27:324-331
25. Petri WA. Infection in heart transplant recipients. Clin Infect Dis 1994; 18:141-148.
26. Muñoz P, Muñoz RM, Palomo J, Rodríguez-Creixéms M, Muñoz R, Bouza E. Pneumocystis carinii infection in Heart transplant recipients. Efficacy of a twice-a-week prophilaxis schedule. Medicine (Baltimore) 1997; 76:415-422.
27. Olsen SL, Renlund DG, O'Connell JB, et al. Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim sulfamethoxazole. Transplantation 1993; 56:359-362.
28. Hayes MJ, Torzillo PJ, Sheil AGR, McCaughan GW. Pneumocystis carinii pneumonia after liver transplantation in adults. Clin Transplant 1994; 8:499-503.
29. Luft BJ, Naot Y, Araujo FJ, Stinson EB, Remington JS. Primary and reactivated Toxoplasma infection in patients with cardiac transplant. Ann Intern Med 1983; 99:27-31.
30. Wreghitt TG, Hakim M, Gray JJ, et al. Toxoplasmosis in heart and heart-lung transplant recipients. J Clin Pathol 1989; 42:194-199.
31. Holliman RE, Johnson JD, Adams S, Pepper JR. Toxoplasmosis and heart transplantation. J Heart Tranplant 1991; 10:608-610.
32. Gallino A, Maggiorini M, Kiowski W, et al. Toxoplasmosis in heart transplant recipients. Eur J Clin Microbiol Infect Dis 1996; 15:389-393.
33. Almirante B, Pahissa A, Planes AM, et al. Etiología de las neumonías extrahospitalarias. Med Clín (Barc) 1985; 85:175-178.
34. Antela A, Guerrero A, Meseguer M, et al. Neumonías extrahospitalarias: estudio prospectivo de 101 pacientes adultos e inmunocompetentes durante un año. Enferm Infecc Microbiol Clin 1993; 11:525-530.
35. Pachón J, Prados MD, Capote F, Cuello JA, Garnacho J, Verano A. Severe community-acquired pneumonia. Etiology, prognosis, and treatment. Am Rev Respir Dis 1990; 142:369-373.